- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04973202
Portrayal of Hospital Alcohol Detoxification in France (Alcostop)
Portrayal of Hospital Alcohol Detoxifications and Factors Associated With Longer or Ulterior Hospitalizations in France From 2011 to 2020
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Context:
In France, the consequences of excessive alcohol use are one of the primary reasons for hospitalization. When stopping the substance, patients with an alcohol use disorder can suffer from a potentially fatal alcohol withdrawal syndrome. To mitigate these risks, a withdrawal under medical supervision is possible, either in an outpatient setting or in hospital, where the detoxification can be programmed or imposed. In the course of an alcohol dependent patient's life, re-drinking is not exceptional and the patient may undergo several withdrawals during his or her life.
Psychiatric pathologies, especially anxiety and depression, are more frequent in these patients than in the rest of the population, just as can be somatic pathologies.e. Withdrawal accidents, represented by comital seizures and delirium tremens, can be critical.
In hospital detoxifications, studies do not show any benefit in continuing the stay beyond 10 days, except in the case of somatic or psychiatric complication. However, little information is available on the average length of stay for hospital alcohol detoxification.
Although alcohol dependence issues are very frequent and the resulting withdrawals are relatively common and associated with numerous comorbidities, little data exists at a national level in France.
The aim of this study is to describe these hospital detoxifications: course, duration, frequency and clinical and paraclinical characteristics of the patients. We also wish to analyze which characteristics are associated with longer stays or re-hospitalization and to compare the care according to the facility type.
Objectives:
Main:
- To describe the clinical, paraclinical, and stay characteristics of hospital alcohol detoxification in France
Secondary:
- To describe the regional distribution of hospital alcohol detoxification
- To evaluate whether certain clinical characteristics are associated with a longer hospital stays
- To evaluate whether certain clinical characteristics are associated with subsequent re-hospitalization for the same reason
- To compare the characteristics of patient stays by type of facility
Methods:
In this descriptive observational study using pre-existing data accessed via the PMSI (Programme de Médicalisation des Systèmes d'Information), we will use all hospital stays from 2011 to 2020 for alcohol detoxification in France, both in public and private settings.
For each hospital stay will be collected the length, the antecedents of hospital alcohol detoxification, clinical and psychiatric comorbidities, withdrawals complication, alcohol use complication, further examinations.
We will describe the stays using median and quartiles for continuous variables and number and percentage for dichotomous variables. For secondary objectives, we will use a multivariate linear regression model if the length of stay is normal, an ordinal regression model otherwise. The characteristics of the stays will be compared regarding the type of facility using univariate comparative tests: Chi² or Fisher for dichotomous variables and Student or Mann-Whitney for continuous variables.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Montpellier, Frankrig, 34295
- Uhmontpellier
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion criteria:
Inclusion criteria:
- French patients of at least 18 years old
- Inpatients of a public or private care facility for alcohol detoxification
- From 01/01/2011 to 12/31/2020
- In a medical or psychiatric hospital
Exclusion criteria:
- age < 18 years
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Inpatients for alcohol detoxifications
French patients who were hospitalized for alcohol detoxification from 2011 to 2020
|
Stay for alcohol detoxification : routine care.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
description of age
Tidsramme: day 1 (At hospital inclusion)
|
Age at admission (in years), calculated by the difference of the year of admission and the year of birth through the PMSI.
|
day 1 (At hospital inclusion)
|
|
description of sex
Tidsramme: day 1 (At hospital inclusion)
|
Sex collected through the PMSI.
|
day 1 (At hospital inclusion)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
description of geographic code
Tidsramme: day 1 (At hospital inclusion)
|
Sex collected through the PMSI.
|
day 1 (At hospital inclusion)
|
|
description of CMU-C
Tidsramme: day 1 (At hospital inclusion)
|
CMU-C (universal complementary health insurance, collected through the PMSI.
|
day 1 (At hospital inclusion)
|
|
Length of stay
Tidsramme: During the stay (day 1 - day 15)
|
Length of stay (in days), calculated by the difference between the discharge date and the entry date, collected through the PMSI.
|
During the stay (day 1 - day 15)
|
|
Care establishment
Tidsramme: During the stay (day 1 - day 15)
|
Name and type of the care establishment, collected through the PMSI.
|
During the stay (day 1 - day 15)
|
|
Number of previous hospital detoxification stays in the studied period
Tidsramme: During the stay (day 1 - day 15)
|
Number of previous hospital detoxification stays in the studied period, collected through the PMSI.
|
During the stay (day 1 - day 15)
|
|
Psychiatric comorbidities
Tidsramme: During the stay (day 1 - day 15)
|
Psychiatric comorbidities (Major depression episode, anxiety, psychotic trouble, personality diseases), collected through the PMSI.
|
During the stay (day 1 - day 15)
|
|
Withdrawal complication
Tidsramme: During the stay (day 1 - day 15)
|
Withdrawal complications (delirium tremens, comitial seizures), collected through the PMSI.
|
During the stay (day 1 - day 15)
|
|
Further examination
Tidsramme: During the stay (day 1 - day 15)
|
Further examination (biology, imagery, etc…), collected through the PMSI.
|
During the stay (day 1 - day 15)
|
|
Re-hospitalization for same reason
Tidsramme: day 1
|
For each patient, and each stay, we will evaluate if the patient had an ulterior re-hospitalization for alcohol withdrawal.
Collected through the PMSI.
|
day 1
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Lionel MOULIS, University Hospital, Montpellier
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RECHMPL21_0456
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Stay for alcohol detoxification
-
Penang Hospital, MalaysiaAfsluttetKontinuerlig ambulatorisk peritonealdialyseMalaysia
-
University of KansasUniversity of North CarolinaRekruttering
-
NYU Langone HealthAfsluttet
-
Division of General Surgery , Mt. Sinai HospitalAfsluttetInflammatoriske tarmsygdomme | Kolorektal cancer | Kirurgi | Udnyttelse, Sundhedsvæsen | Overvågning efter udskrivningCanada
-
Yale UniversityNational Institute of Mental Health (NIMH); Teachers College, Columbia...Tilmelding efter invitationSelvmordsforebyggelse | Depression i ungdomsåreneForenede Stater
-
Central Hospital, Nancy, FranceAfsluttetSelvmord og selvskadeFrankrig
-
Chinese University of Hong KongAfsluttetKardiovaskulær sygdom | Nyresvigt | ESRDHong Kong
-
Maastricht University Medical CenterDutch Health Care Insurance Board (nr: 00106), Amstelveen, The NetherlandsAfsluttet
-
Albert Einstein College of MedicineNational Institute on Drug Abuse (NIDA)AfsluttetKronisk smerte | Opioid-relaterede lidelser | Opioidbrugsforstyrrelse | Stemningsændring | Misbrug af opioidForenede Stater
-
Auburn UniversityIkke rekrutterer endnuAlkohol drikkeForenede Stater